PainChek Limited (PCK.AX)
PainChek Limited operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.10, up 0.00% on the session, giving a market capitalisation of $21.9M. Its beta of 0.47 implies it has historically moved less than the broad market.
PainChek Limited specializes in the creation and commercialization of mobile medical applications designed for individual pain assessment. Their core product, PainChek, employs smartphone and tablet cameras to record video, which is then analyzed in real-time by facial recognition software to detect the presence of pain. This technology is particularly beneficial for patients suffering from dementia. The company, which operates from its headquarters in Sydney, Australia, rebranded as PainChek Limited in January 2018, having previously been known as ePAT Technologies Ltd.
PainChek Limited is most often compared with the following Healthcare names: